FindTrial
Sign In

Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma

Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000028725
Enrollment
Unknown
Registered
2020-01-01
Start date
2020-01-15
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

1:MWA
2:RFA

Sponsors

Qiang Zhu
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. aged older than 18 years; 2. up to 3 tumor nodules with each nodule <=5 cm; 3. Child-Pugh class A or B.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had extra-hepatic metastasis at HCC diagnosis and/or other significant comorbidity such as other malignancies, cardiopulmonary compromise or renal failure.

Design outcomes

Primary

MeasureTime frame
overall survival;—

Countries

China

Contacts

Public ContactYuemin Feng

Shandong Provincial Hospital Affiliated to Shandong University

sdyueminfeng@163.com+86 17865137793

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026